Also known as Aranesp
Darbepoetin alfa (rINN) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.Source: Wikipedia
Estimated Total Cost: $1003.65 for an average of 21 days supply
Patients are most commonly prescribed darbepoetin alfa to treat chronic kidney disease, anemia, fatigue, and anemia due to chronic kidney disease.